text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

Base-modified Ribonucleoside Triphosphates for mRNA Drug Discovery

RNA base-modified ribonucleoside triphosphate is used in in vitro transcription (IVT) of RNA medicines. RNA vaccines work by inducing the body to express viral proteins, which in turn stimulate the immune system to produce antibodies. In this process, the mRNA's own evasion of the immune system is important, along with the mRNA's translational efficiency. It is known that swapping nucleotides for a related analogue helped to make the mRNA less conspicuous to the immune system.1)
TCI has commercialized N1-methyl pseudouridine 5'-triphosphate sodium salt (Product No. M3544), pseudouridine 5'-triphosphate sodium salt (Product No. P3045), 5-methyluridine 5'-triphosphate sodium salt (Product No. M3582), 5-methylcytidine 5'-triphosphate sodium salt (Product No. M3583), 5-methoxyuridine 5'-triphosphate sodium salt (Product No. M3584) which are expected to have high translational efficiency and immunogenicity reduction effects, as raw materials for the synthesis of modified RNA medicines.2-6) These products have been checked for DNase and RNase contamination and functionality in IVT.

In recent years, studies in this field have been very active, new effects of base-modified nucleotides are continuously being reported. TCI is capable of performing the full process from modification of bases to triphosphorylation in-house, and can also provide base-modified triphosphates that are not listed in our catalog. TCI are also available for consultation on scale-up manufacturing.

Products

Page Top

References

Page Top

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.